Veracyte, Inc. (VCYT) stock
VCYTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3029% below fair value
$25.13+0.09 (+0.36%)
Close on Nov 20, 2026Market cap $2.02BP/E 17.9Yield –
Veracyte shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Veracyte's shares outstanding was 82M at Jun 30, 2026. For fiscal 2025 it was 81M, up 3.1% from the year before. Over ten years it grew 12.0% a year on average. The highest annual figure on record is 81M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 81M | +3.1% |
| FY2024 | Dec 31, 2024 | 78M | +7.6% |
| FY2023 | Dec 31, 2023 | 73M | +1.5% |
| FY2022 | Dec 31, 2022 | 72M | +5.4% |
| FY2021 | Dec 31, 2021 | 68M | +27.5% |
| FY2020 | Dec 31, 2020 | 53M | +15.4% |
| FY2019 | Dec 31, 2019 | 46M | +24.6% |
| FY2018 | Dec 31, 2018 | 37M | +9.1% |
| FY2017 | Dec 31, 2017 | 34M | +17.7% |
| FY2016 | Dec 31, 2016 | 29M | +10.9% |
| FY2015 | Dec 31, 2015 | 26M | +20.1% |
| FY2014 | Dec 31, 2014 | 22M | +420.3% |
| FY2013 | Dec 31, 2013 | 4M | +539.5% |
| FY2012 | Dec 31, 2012 | 1M | +12.1% |
| FY2011 | Dec 31, 2011 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 82M | +4.7% |
| Q1 FY2026 | Mar 31, 2026 | 81M | +1.6% |
| Q4 FY2025 | Dec 31, 2025 | 82M | +2.3% |
| Q3 FY2025 | Sep 30, 2025 | 80M | +1.6% |
| Q2 FY2025 | Jun 30, 2025 | 78M | +1.6% |
| Q1 FY2025 | Mar 31, 2025 | 80M | +7.1% |
| Q4 FY2024 | Dec 31, 2024 | 81M | +10.3% |
| Q3 FY2024 | Sep 30, 2024 | 78M | +7.8% |
| Q2 FY2024 | Jun 30, 2024 | 77M | +6.5% |
| Q1 FY2024 | Mar 31, 2024 | 75M | +3.6% |
| Q4 FY2023 | Dec 31, 2023 | 73M | +1.8% |
| Q3 FY2023 | Sep 30, 2023 | 73M | +1.6% |
| Q2 FY2023 | Jun 30, 2023 | 72M | +1.4% |
| Q1 FY2023 | Mar 31, 2023 | 72M | +1.3% |
| Q4 FY2022 | Dec 31, 2022 | 72M | +1.0% |
| Q3 FY2022 | Sep 30, 2022 | 72M | +2.7% |
| Q2 FY2022 | Jun 30, 2022 | 71M | +6.2% |
| Q1 FY2022 | Mar 31, 2022 | 71M | +12.5% |
| Q4 FY2021 | Dec 31, 2021 | 71M | +22.5% |
| Q3 FY2021 | Sep 30, 2021 | 70M | +27.1% |
| Q2 FY2021 | Jun 30, 2021 | 67M | +34.1% |
| Q1 FY2021 | Mar 31, 2021 | 63M | +27.2% |
| Q4 FY2020 | Dec 31, 2020 | 58M | +18.2% |
| Q3 FY2020 | Sep 30, 2020 | 55M | +12.9% |
| Q2 FY2020 | Jun 30, 2020 | 50M | +10.1% |
| Q1 FY2020 | Mar 31, 2020 | 50M | +20.9% |
| Q4 FY2019 | Dec 31, 2019 | 49M | +20.5% |
| Q3 FY2019 | Sep 30, 2019 | 49M | +25.8% |
| Q2 FY2019 | Jun 30, 2019 | 46M | +32.8% |
| Q1 FY2019 | Mar 31, 2019 | 41M | +20.1% |
| Q4 FY2018 | Dec 31, 2018 | 41M | +16.2% |
| Q3 FY2018 | Sep 30, 2018 | 39M | +13.8% |
| Q2 FY2018 | Jun 30, 2018 | 34M | +1.3% |
| Q1 FY2018 | Mar 31, 2018 | 34M | +1.3% |
| Q4 FY2017 | Dec 31, 2017 | 35M | +10.6% |
| Q3 FY2017 | Sep 30, 2017 | 34M | +21.6% |
| Q2 FY2017 | Jun 30, 2017 | 34M | – |
| Q1 FY2017 | Mar 31, 2017 | 34M | – |
| Q4 FY2016 | Dec 31, 2016 | 32M | – |
| Q3 FY2016 | Sep 30, 2016 | 28M | – |
See a number that looks wrong?